Inquire About a Product| Product: | 1,2-Benzisoxazole-3-methanesulfonate sodium salt | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| Catalog Number: | 4773 | ||||||||
| CAS Number: | 73101-64-1 | ||||||||
| Synonyms: | Zonisamide related compound A | ||||||||
| Pricing: |
|
||||||||
| Formula: | C8H6NNaO4S | ||||||||
| Chemical Purity: | 95% | ||||||||
| Molecular Weight: | 235.19 | ||||||||
| Appearance: | Solid | ||||||||
| Category: | Unlabeled Reference Standards | ||||||||
| Stability: | Stable under recommended storage conditions | ||||||||
| Storage: |
Keep container tightly closed in a dry and well ventilated place |
||||||||
| Transportation: |
Non-hazardous for transport |
||||||||
| Literature References: |
Tomson., T., Johannessen, S., Therapeutic monitoring of the new antiepileptic drugs. Eur. J. Pharmacol. 55, 697, (2000); Noda, Y., et al., Zonisamide inhibits nitric oxide synthase activity induced by N-methyl-D-aspartate and buthionine sulfoximine in the rat hippocampus. Res. Commun. Mol. Pathol. Pharmacol. 105, 23, (1999); Merck 14,10192 |
||||||||
| MSDS: | |||||||||
| Description: |
Zonisamide sodium salt is an anti-epileptic. It is effective in various animal epilepsy models and humans with both partial and generalized epileptic seizures. Zonisamide sodium salt also scavenges nitric oxide (NO). |